Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nanotech Biomachines

Nanotech Biomachines
2008 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
4 INVESTORS
Description

Producer of industrial-grade graphene intended for industrial electronic applications. The company's industrial-grade graphene develops graphene sheets, substrates and nano-materials for defense, semiconductor, biodetection and other applications, enabling users to get large monolayers and double layers for electronic applications.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Energy
Other Industries
Other Energy Services
Primary Office
  • 2600 Hilltop Drive
  • Building B, Suite C110
  • Richmond, CA 94806
  • United States

+1 (855) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nanotech Biomachines’s full profile, request a free trial.

Nanotech Biomachines Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 01-Jan-2017 00000 Completed Startup
3. Convertible Debt 27-Apr-2015 0000 00000 Completed Startup
2. Accelerator/Incubator 26-Apr-2013 $105K Completed Startup
1. Convertible Debt 23-May-2012 $105K $105K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Nanotech Biomachines Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Band of Angels Angel Group Minority 000 0000 000000 0
Life Science Angels Angel Group Minority 000 0000 000000 0
John F. Kennedy University University Minority 000 0000 000000 0
Sand Hill Angels Angel Group Minority 000 0000 000000 0

Nanotech Biomachines Executive Team (3)

Name Title Board
Seat
Contact
Info
Will Martinez Founder, Chief Executive Officer & Chief Technology Officer
Frank Robinson Vice President, Product Development

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »